American Academy of Neurology (AAN) Guideline Summary for Clinicians: Evaluation of the Child with Global Developmental Delay

Print QualityTool

E-mail a Link

Description

This two-page tool is a summary of the American Academy of Neurology and Child Neurology Society guideline on diagnosis of the child with global developmental delay. This practice parameter reviewed available evidence concerning the value of diagnostic testing in the initial evaluation of a young child with a global developmental delay that is static and nonprogressive and has no clear etiology.

This summary presents specific recommendations for each of the following testing modalities:

Metabolic screening
Cytogenetic testing
Fragile X testing
Rett syndrome testing
Molecular techniques
Lead screening
Thyroid screening
Electroencephalography
Neuroimaging
Hearing and vision testing

This tool includes a flowchart to guide the diagnostic process.

Links to the Tool:

This tool is available at: http://aan.com/professionals/practice/guidelines/guideline_summaries/Global _Devlopmental_Delay_Clinicians.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software.)

Developer

American Academy of Neurology; Child Neurology Society

Funding Sources

American Academy of Neurology

QualityTool Topic

Disease/Condition-Related; Guideline-Related

Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=4106&string=

History

Release Date: 02/2003
Original Summary: 09/2004

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

QualityTool Classification

Disease/Clinical Category:		Fragile x syndrome; Global developmental delay; Rett's disorder
Patient Population:		Age > Infant (1-23 months); Preschooler (2-5 years); Vulnerable Populations > Children; Disabled (developmentally)
Patient Care Process:		Preventive Care Processes > Screening; Active Care Processes: Diagnosis and Treatment > Assessment; Imaging; Laboratory tests
IOM Domains of Quality:		Effectiveness
QualityTool Format:		Algorithm/Flowchart; Workbook/Manual/Guide
QualityTool Topic:		Disease/Condition-Related; Guideline-Related
Developer:		American Academy of Neurology; Child Neurology Society
Funding Sources:		American Academy of Neurology

Last updated: July 28, 2009.